Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
2016 ◽
Vol 28
(1)
◽
pp. 389-398
◽
Keyword(s):
2016 ◽
Vol 18
(12)
◽
pp. 1207-1216
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 98
(5)
◽
pp. 53
Keyword(s):